Fragile dynamics enable diverse genomic determinants to influence arrhythmia propensity
Tim J. Kamerzell, Eric A. SobieiD, Kai-Chen Yang, Jeanne M. NerbonneiD, Calum A. MacRaeiD, Ravi IyengariD
Abstract
Genotype-phenotype relationships are determinants of human diseases. Often, we know little about why so many genes are involved in complex common diseases. We hypothesized that this multigene effect arises from the relationship between genes and physiological dynamics. We tested this hypothesis for arrhythmias as physiological dynamics define this disease. We integrated graph theory analysis of genomic and protein-protein interaction networks with dynamical models of ion channel function to identify the physiological dynamics of genome wide variation for five different arrhythmias. Regulatory networks for the cardiac conduction system and arrhythmias were constructed from GWAS and known disease genes. Electrophysiological models of myocyte action potentials were used to conduct extensive parameter variations to identify robust and fragile kinetic parameters that were then, using regulatory networks, associated with genomic determinants. We find that genome-wide determinants of arrhythmias that represent many cellular processes are selectively associated with fragile physiological dynamics of ion channel kinetics. This association predicts disease propensity. Deep RNA sequencing from human left ventricular tissue of arrhythmia and control subjects confirmed the predictive relationship. Taken together these studies show that the varied multigene effects of arrhythmias arises because of associations with fragile kinetic parameters of cardiac electrophysiology.\n\nSignificance StatementOur understanding of the genetics of common diseases has advanced exponentially over the past decade. We now know that differences and variation in multiple genes contribute to disease susceptibility with significant heterogeneity in the phenotype. However, how genetic variation contributes to disease phenotypes remains unknown. We hypothesized that the relationships between physiological dynamics and genetic architecture is a fundamental determinant of disease susceptibility and genetic heterogeneity. To test our hypothesis, we integrated mathematical models of cardiac electrophysiology with genetic network models of cardiac arrhythmias. We found that disease related genome variants were selectively associated with fragile kinetic parameters that predict disease propensity and identified several novel cellular processes associated with arrhythmogenesis.
02 /Specification & Classification
Click any tag to browse matching papers- Citations
- 0
- Organism
- Assay
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Genome-wide association study of 1 million people identifies 111 loci for atrial fibrillation
Jonas Bille Nielsen, Rósa B. Þórólfsdóttir, … Cristen J. Willer·Nature GeneticsPeer-reviewed·Jul 26, 2018
- Reduced gap junction coupling amplifies the effects of cardiomyocyte variability and destabilizes the heartbeat
Karoline Horgmo Jæger, William Edward Louch, Aslak Tveito·Physiological ReportsPeer-reviewed·Jul 1, 2025
- Arrhythmia variant associations and reclassifications in the eMERGE-III sequencing study
Andrew Michael Glazer, Giovanni Davogustto, … Dan M. Roden·CirculationPeer-reviewed·Dec 21, 2021
- Associations of schizophrenia with arrhythmic disorders and electrocardiogram traits: an in-depth genetic exploration of population samples
Jorien L. Treur, Anaïs B Thijssen, … Karin J. H. Verweij·medRxiv·May 21, 2023
- Genetic analyses of the QT interval and its components in over 250K individuals identifies new loci and pathways affecting ventricular depolarization and repolarization
William John Young, Najim Lahrouchi, … Antônio Luiz Pinho Ribeiro·Nature CommunicationsPeer-reviewed·Sep 1, 2022
- Multiplatform Modeling of Atrial Fibrillation Identifies Phospholamban as Central Regulator of Cardiac Rhythm
A. Colas, K. Ocorr, … A. Kervadec·bioRxiv·Sep 23, 2022